Epigenetic modulations of induced pluripotent stem cells: Novel therapies and disease models

Drug Discovery Today: Disease Models

Volumn 9, Issue 4, 2012, Pages

  Huang, Chengyang ^a   Wu, Joseph C ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZACITIDINE; DNA METHYLTRANSFERASE 1; HISTONE DEACETYLASE; HISTONE METHYLTRANSFERASE; KRUPPEL LIKE FACTOR 4; MYC PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; SHORT CHAIN FATTY ACID; TRANSCRIPTION FACTOR SOX2; TRICHOSTATIN A; VALPROIC ACID; VORINOSTAT;

ARTICLE; CELL DIFFERENTIATION; DEMETHYLATION; DNA METHYLATION; EPIGENETICS; FIBROBLAST; GENETIC DISORDER; GENETIC VARIABILITY; GENOME; HISTONE METHYLATION; HISTONE MODIFICATION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PARKINSON DISEASE; PLURIPOTENT STEM CELL; REGULATORY MECHANISM; SICKLE CELL ANEMIA; SOMATIC CELL; SUBSTITUTION THERAPY;

EID: 84876684240     PISSN: None     EISSN: 17406757     Source Type: Journal    
DOI: 10.1016/j.ddmod.2012.02.004     Document Type: Review

References (66)

1. K. Takahashi, and S. Yamanaka Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors Cell 126 2006 663 676
2. K. Okita Generation of germline-competent induced pluripotent stem cells Nature 448 2007 313 317
3. J. Yu Induced pluripotent stem cell lines derived from human somatic cells Science 318 2007 1917 1920
4. M. Wernig In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state Nature 448 2007 318 324
5. I.H. Park Reprogramming of human somatic cells to pluripotency with defined factors Nature 451 2008 141 146
6. K. Woltjen piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells Nature 458 2009 766 770
7. K. Kaji Virus-free induction of pluripotency and subsequent excision of reprogramming factors Nature 458 2009 771 775
8. J. Yu Human induced pluripotent stem cells free of vector and transgene sequences Science 324 2009 797 801
9. F. Jia A nonviral minicircle vector for deriving human iPS cells Nature Methods 7 2010 197 199
10. D. Kim Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins Cell Stem Cell 4 2009 472 476
11. L. Warren Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA Cell Stem Cell 7 2010 618 630
12. F. Anokye-Danso Highly efficient miRNA-mediated reprogramming of mouse and human somatic cells to pluripotency Cell Stem Cell 8 2011 376 388
13. H. Ban Efficient generation of transgene-free human induced pluripotent stem cells (iPSCs) by temperature-sensitive Sendai virus vectors Proc. Natl. Acad. Sci. U.S.A. 108 2011 14234 14239
14. H. Li The Ink4/Arf locus is a barrier for iPS cell reprogramming Nature 460 2009 1136 1139
15. D. Huangfu Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2 Nat. Biotechnol. 26 2008 1269 1275
16. N. Sun Human iPS cell-based therapy: considerations before clinical applications Cell Cycle 9 2010 880 885
17. S.M. Wu, and K. Hochedlinger Harnessing the potential of induced pluripotent stem cells for regenerative medicine Nat. Cell Biol. 13 2011 497 505
18. B.E. Bernstein The mammalian epigenome Cell 128 2007 669 681
19. H. Cedar, and Y. Bergman Linking DNA methylation and histone modification: patterns and paradigms Nat. Rev. Genet. 10 2009 295 304
20. R.J. Sims 3rd, and D. Reinberg Histone H3 Lys 4 methylation: caught in a bind? Genes Dev. 20 2006 2779 2786
21. C. Huang Dual-specificity histone demethylase KIAA1718 (KDM7A) regulates neural differentiation through FGF4 Cell Res. 20 2010 154 165
22. P. Hajkova Epigenetic reprogramming-taking a lesson from the embryo Curr. Opin. Cell Biol. 22 2010 342 350
23. T.S. Mikkelsen Dissecting direct reprogramming through integrative genomic analysis Nature 454 2008 49 55
24. R.P. Koche Reprogramming factor expression initiates widespread targeted chromatin remodeling Cell Stem Cell 8 2011 96 105
25. S. Kishigami Significant improvement of mouse cloning technique by treatment with trichostatin A after somatic nuclear transfer Biochem. Biophys. Res. Commun. 340 2006 183 189
26. R. Blelloch Reprogramming efficiency following somatic cell nuclear transfer is influenced by the differentiation and methylation state of the donor nucleus Stem Cells 24 2006 2007 2013
27. Y. Ohi Incomplete DNA methylation underlies a transcriptional memory of somatic cells in human iPS cells Nat. Cell Biol. 13 2011 541 549
28. Y. Shi Induction of pluripotent stem cells from mouse embryonic fibroblasts by Oct4 and Klf4 with small-molecule compounds Cell Stem Cell 3 2008 568 574
29. D.K. Ma G9a and Jhdm2a regulate embryonic stem cell fusion-induced reprogramming of adult neural stem cells Stem Cells 26 2008 2131 2141
30. D. Huangfu Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds Nat. Biotechnol. 26 2008 795 797
31. G. Liang Butyrate promotes induced pluripotent stem cell generation J. Biol. Chem. 285 2010 25516 25521
32. P. Mali Butyrate greatly enhances derivation of human induced pluripotent stem cells by promoting epigenetic remodeling and the expression of pluripotency-associated genes Stem Cells 28 2010 713 720
33. C.F. Pereira ESCs require PRC2 to direct the successful reprogramming of differentiated cells toward pluripotency Cell Stem Cell 6 2010 547 556
34. Z. Zhang PRC2 complexes with JARID2, MTF2, and esPRC2p48 in ES cells to modulate ES cell pluripotency and somatic cell reprogramming Stem Cells 29 2011 229 240
35. M.H. Chin Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures Cell Stem Cell 5 2009 111 123
36. M.C. Marchetto Transcriptional signature and memory retention of human-induced pluripotent stem cells PloS One 4 2009 e7076
37. Z. Ghosh Persistent donor cell gene expression among human induced pluripotent stem cells contributes to differences with human embryonic stem cells PloS One 5 2010 e8975
38. K.H. Narsinh Single cell transcriptional profiling reveals heterogeneity of human induced pluripotent stem cells J. Clin. Investig. 121 2011 1217 1221
39. M. Pick Clone- and gene-specific aberrations of parental imprinting in human induced pluripotent stem cells Stem Cells 27 2009 2686 2690
40. J. Deng Targeted bisulfite sequencing reveals changes in DNA methylation associated with nuclear reprogramming Nat. Biotechnol. 27 2009 353 360
41. A. Doi Differential methylation of tissue- and cancer-specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts Nat. Genet. 41 2009 1350 1353
42. R. Lister Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells Nature 471 2011 68 73
43. A.M. Newman, and J.B. Cooper Lab-specific gene expression signatures in pluripotent stem cells Cell Stem Cell 7 2010 258 262
44. H. Masaki Heterogeneity of pluripotent marker gene expression in colonies generated in human iPS cell induction culture Stem Cell Res. 1 2007 105 115
45. K.M. Loh, and B. Lim Recreating pluripotency? Cell Stem Cell 7 2010 137 139
46. M. Stadtfeld Aberrant silencing of imprinted genes on chromosome 12qF1 in mouse induced pluripotent stem cells Nature 465 2010 175 181
47. K. Kim Epigenetic memory in induced pluripotent stem cells Nature 467 2010 285 290
48. J.M. Polo Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells Nat. Biotechnol. 28 2010 848 855
49. K. Nishino DNA methylation dynamics in human induced pluripotent stem cells over time PLoS Genet. 7 2011 e1002085
50. O. Bar-Nur Epigenetic memory and preferential lineage-specific differentiation in induced pluripotent stem cells derived from human pancreatic islet Beta cells Cell Stem Cell 9 2011 17 23
51. Q. Hu Memory in induced pluripotent stem cells: reprogrammed human retinal-pigmented epithelial cells show tendency for spontaneous redifferentiation Stem Cells 28 2010 1981 1991
52. W. Reik Stability and flexibility of epigenetic gene regulation in mammalian development Nature 447 2007 425 432
53. R.J. Swijnenburg Immunosuppressive therapy mitigates immunological rejection of human embryonic stem cell xenografts Proc. Natl. Acad. Sci. U.S.A. 105 2008 12991 12996
54. J. Hanna Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin Science 318 2007 1920 1923
55. M. Wernig Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease Proc. Natl. Acad. Sci. U.S.A. 105 2008 5856 5861
56. K. Narsinh Derivation of human induced pluripotent stem cells for cardiovascular disease modeling Circ. Res. 108 2011 1146 1156
57. J.L. Medina-Franco, and T. Caulfield Advances in the computational development of DNA methyltransferase inhibitors Drug Discov. Today 16 2011 418 425
58. M. Paris Histone deacetylase inhibitors: from bench to clinic J. Med. Chem. 51 2008 1505 1529
59. R. Juttermann Toxicity of 5-aza-2(-deoxycytidine to mammalian cells is mediated primarily by covalent trapping of DNA methyltransferase rather than DNA demethylation Proc. Natl. Acad. Sci. U.S.A. 91 1994 11797 11801
60. J.T. Dimos Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons Science 321 2008 1218 1221
61. F. Soldner Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors Cell 136 2009 964 977
62. A.D. Ebert Induced pluripotent stem cells from a spinal muscular atrophy patient Nature 457 2009 277 280
63. I.H. Park Disease-specific induced pluripotent stem cells Cell 134 2008 877 886
64. A. Moretti Patient-specific induced pluripotent stem-cell models for long-QT syndrome N. Engl. J. Med. 363 2010 1397 1409
65. X. Carvajal-Vergara Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndrome Nature 465 2010 808 812
66. F. Cao Transcriptional and functional profiling of human embryonic stem cell-derived cardiomyocytes PloS One 3 2008 e3474